跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 7,020 条关于
“Poly(ADP-ribose) glycohydrolase”
全部
7,020
临床试验
5,296
药物
873
机构
45
资讯
806
去年
IDEAYA Doses First Patient in Phase 1 Trial of IDE161 and Keytruda Combination for Endometrial Cancer
8个月前
858 Therapeutics Receives FDA Fast Track Designation for PARG Inhibitor ETX-19477 in BRCA-Mutated Ovarian Cancer
9个月前
FoRx Therapeutics Secures $50M Series A to Advance PARG Inhibitor for PARP-Resistant Cancers
4个月前
858 Therapeutics' PARG Inhibitor ETX-19477 Shows 57% ORR in BRCA-Mutated Ovarian and Breast Cancer, Earns FDA Fast Track Designation
5年前
Comparative Analysis of PARP Inhibitors in BRCA-Mutated Ovarian Cancer Shows Similar Efficacy and Toxicity
6年前
PARP Inhibitors Show Similar Efficacy in BRCA-Mutated Ovarian Cancer, Cost-Effectiveness Varies
去年
FoRx Therapeutics Doses First Patient with Novel PARG Inhibitor FORX-428 in Phase 1 Cancer Trial
12年前
Niraparib Maintenance Therapy Demonstrates Sustained Benefit in Recurrent Ovarian Cancer
4年前
PARP Inhibitors Show Promise in Ovarian Cancer Maintenance Therapy
11年前
PARP Inhibitors Show Promise in Epithelial Ovarian and Breast Cancers with BRCA1/2 Mutations
第 1 页，共 81 页
上一页
下一页
